Filtered By:
Therapy: Chemotherapy
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 56 results found since Jan 2013.
How much sunshine is just the right amount?
This morning I awoke to a picture of myself in the Wall Street Journal. I was asked to comment on the effects of the coming Sunshine Act. Respected health care journalist Peter Loftus found me through social media channels.
What follows are some thoughts about how the Sunshine Act will play out.
—
Every Thursday during my cardiac fellowship training, at noontime, the entire department gathered for an hour-long conference on Echocardiography. Unknown images were shown and trainees took turns getting grilled. Faculty ‘commented’ from the back of the classroom. There was, shall we say, a spirited tone to the learnin...
Source: Dr John M - August 23, 2013 Category: Cardiology Authors: Dr John Source Type: blogs
AngioDynamics BioFlo Port with Endexo Technology Helps Prevent Thrombus Accumulation, Gets FDA Nod
Navilyst Medical, an AngioDynamics company, received FDA clearance for its BioFlo Port with Endexo technology. The port is designed to be placed under the skin for long term delivery of medication, chemotherapy, blood draws, or for IV feeding. The E...
Source: Medgadget - August 21, 2013 Category: Technology Consultants Authors: Editors Tags: Cardiology Critical Care Oncology Surgery Vascular Surgery Source Type: blogs
Changing the culture of American Medicine — Start by removing hubris
This may be the most important post I have ever published. I’m going to tell you about a study that should change the entire way doctors approach patients, and how patients should think of prescribed treatments. These findings should begin a culture change in American medicine.
Background:
I used to think Medicine would get easier over time. It makes sense, right? You see patterns, you learn how treatments work, and you just get to know stuff. Experience should make it easier to diagnose and treat.
That’s not been the case for me. In fact, it’s closer to the opposite. In the exam room, as I look up to the patient fro...
Source: Dr John M - July 28, 2013 Category: Cardiology Authors: Dr John Source Type: blogs
Radiation associated heart disease
Which statement about radiation associated heart disease is not true?
a) Risk is higher in those who received chemotherapy with agents like anthracyclines in addition to radiation
b) Less common in survivors of breast cancer and Hodgkin’s disease
c) Could involve all the three layers of the heart with pericarditis, myocardial fibrosis or dysfunction, and valvular damage
d) Can cause co-existence of restrictive heart disease with constrictive pericarditis
Correct answer: b) Less common in survivors of breast cancer and Hodgkin’s disease
Radiation associated heart disease is more noted in survivors of breast cancer...
Source: Cardiophile MD - July 23, 2013 Category: Cardiology Authors: Prof. Dr. Johnson Francis MD, DM, FACC, FRCP Edin, FRCP London Tags: Cardiology MCQ DM / DNB Cardiology Entrance Source Type: blogs
Cardiology MCQ Test 6
Cardiology MCQ Online 6
Time limit: 0
Quiz-summary
0 of 25 questions completed
Questions:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
You are welcome to try this MCQ set and share it among your friends. Answer key with explanation appears after you complete the test and submit it and press on the view questions button. W...
Source: Cardiophile MD - July 16, 2013 Category: Cardiology Authors: Prof. Dr. Johnson Francis MD, DM, FACC, FRCP Edin Tags: Cardiology MCQ DM / DNB Cardiology Entrance Source Type: blogs
#187: Beet this: More evidence of BP-lowering effects of dietary nitrate; amiodarone-cancer link reemerges in observational study; ACE inhibitor, beta-blocker may thwart cardiotoxicity from chemotherapy; will new FDA meeting on Avandia prompt withdrawal?
Beet this: More evidence of BP-lowering effects of dietary nitrate; amiodarone-cancer link reemerges in observational study; ACE inhibitor, beta-blocker may thwart cardiotoxicity from chemotherapy; will new FDA meeting on Avandia prompt withdrawal o
Source: Blogs@theHeart.org - April 19, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: blogs
Transcript of Dr. Bihari Video
00:00 to 02.26—Dr. Bihari gives his background and credentials.
Dr. Bihari: My medical training started at Harvard Medical School. I graduated in 1957. Then I trained in Internal Medicine at one of the Harvard teaching hospitals in Boston, Beth Israel, and then in Neurology at Massachusetts General in Boston. Then I went to the National Institutes of Health for two years doing brain physiology—brain research. I did another residency training in Psychiatry in New York, at Columbia Presbyterian Medical Center and then, over the following five or six years, I got very involved in working in Drug Addiction. By 1974, I was...
Source: HONEST MEDICINE: My Dream for the Future - May 16, 2011 Category: Consumer Health News Authors: JuliaS1573 at aol.com (Julia Schopick) Tags: Anecdotal Treatments HONEST MEDICINE Integrative Medicine Low Dose Naltrexone Obituaries Source Type: blogs
